EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) shares were down 7.8% during mid-day trading on Tuesday . The stock traded as low as $140.93 and last traded at $141.3950. Approximately 225,897 shares traded hands during mid-day trading, an increase of 136% from the average daily volume of 95,598 shares. The stock had previously closed at $153.35.
Analyst Ratings Changes
A number of research analysts have weighed in on ESLOY shares. HSBC upgraded shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Wednesday, January 14th. UBS Group upgraded EssilorLuxottica from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 27th. Zacks Research cut EssilorLuxottica from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 18th. Royal Bank Of Canada reiterated an "outperform" rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. Finally, The Goldman Sachs Group reissued a "buy" rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy".
View Our Latest Analysis on ESLOY
EssilorLuxottica Stock Down 6.5%
The stock's fifty day moving average price is $158.34 and its 200-day moving average price is $163.60. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18.
About EssilorLuxottica
(
Get Free Report)
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EssilorLuxottica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.
While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.